Search - tctmd.com

Displaying 1 - 20 of 137

Sort: Relevancy | Date

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

February 06, 2026

Telemedicine May Adversely Impact Care Quality for HF Patients

News Daily News

Telemedicine May Adversely Impact Care Quality for HF Patients

January 26, 2026

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

October 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

October 25, 2025

Lowering Novel Biomarker, GDF-15, Raises HF Event Rate: GARDEN-TIMI 74

News Conference News HFSA 2025

Lowering Novel Biomarker, GDF-15, Raises HF Event Rate: GARDEN-TIMI 74

Yael L. Maxwell

September 30, 2025

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

News Daily News

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

September 26, 2025

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

News Conference News ESC 2025

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Michael O'Riordan

August 31, 2025

Starting SGLT2 inhibitors in the Hospital for Acute HF Gains Support

News Conference News ESC 2025

Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support

August 30, 2025

Boosting Potassium Helps Patients at High Risk for Ventricular Arrhythmias

News Conference News ESC 2025

Boosting Potassium Helps Patients at High Risk for Ventricular Arrhythmias

August 29, 2025

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

August 13, 2025

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

TCTMD’s Top 10 Most Popular Stories for June 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

Cardiology Consults Tied to Better Outcomes in Patients With HF

News Conference News ESC Heart Failure 2025

Cardiology Consults Tied to Better Outcomes in Patients With HF

May 19, 2025

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

May 09, 2025

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

News Conference News SCAI 2025

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

May 09, 2025

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

News Conference News HRS 2025

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

May 02, 2025

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

News Conference News ACC 2025

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

Michael O'Riordan

April 01, 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

March 30, 2025

CV Screening, Care at UK Football Club Made Inroads Against HF

News Daily News

CV Screening, Care at UK Football Club Made Inroads Against HF

March 07, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.